
Dicyclomine (10mg) + Mefenamic Acid (250mg)
Cipla Ltd
Dicyclomine 10mgPack Size
Strip of 10 tablets
Price
Save ₹20
that's 42% off!
Active composition
+1 more active ingredient
Dicyclomine inhibits acetylcholine at muscarinic receptors, leading to relaxation of smooth muscle in the gastrointestinal tract.
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
Kayspas-Plus Tablet is a combination medication containing Dicyclomine 10 mg and Mefenamic Acid 250 mg, formulated to provide effective relief from gastrointestinal spasms and associated pain. Dicyclomine is an anticholinergic agent that works by relaxing the smooth muscles of the gastrointestinal tract, thereby reducing muscle spasms, cramps, and discomfort commonly seen in conditions such as irritable bowel syndrome (IBS) and other functional bowel disorders. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, which reduces the synthesis of prostaglandins responsible for pain and inflammation. The synergistic action of these two components makes Kayspas-Plus particularly effective in managing abdominal pain accompanied by spasmodic activity. It is indicated for the symptomatic treatment of abdominal cramps, dysmenorrhea, and other conditions involving smooth muscle spasms with inflammatory pain. Kayspas-Plus should be used under medical supervision, with caution advised in patients with a history of gastrointestinal ulcers, bleeding disorders, or hypersensitivity to NSAIDs or anticholinergic agents. Common side effects may include dry mouth, dizziness, nausea, and mild gastrointestinal disturbances.
How to use Kayspas-Plus Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kayspas-Plus Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Kayspas-Plus Tablet. Please consult your doctor.
High Risk
Information regarding the use of Kayspas-Plus Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Kayspas-Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Kayspas-Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Kayspas-Plus Tablet may be needed. Please consult your doctor.
Regular Checkup
Information regarding the use of Kayspas-Plus Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kayspas-Plus Tablet should be used with caution in patients with kidney disease. Dose adjustment of Kayspas-Plus Tablet may be needed. Please consult your doctor. Use of Kayspas-Plus Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Kayspas-Plus Tablet

Dicyclomine (10mg) + Mefenamic Acid (250mg)
Cipla Ltd
Dicyclomine 10mgPack Size
Strip of 10 tablets
Price
Save ₹20
that's 42% off!
Active composition
+1 more active ingredient
Dicyclomine inhibits acetylcholine at muscarinic receptors, leading to relaxation of smooth muscle in the gastrointestinal tract.
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
Kayspas-Plus Tablet is a combination medication containing Dicyclomine 10 mg and Mefenamic Acid 250 mg, formulated to provide effective relief from gastrointestinal spasms and associated pain. Dicyclomine is an anticholinergic agent that works by relaxing the smooth muscles of the gastrointestinal tract, thereby reducing muscle spasms, cramps, and discomfort commonly seen in conditions such as irritable bowel syndrome (IBS) and other functional bowel disorders. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, which reduces the synthesis of prostaglandins responsible for pain and inflammation. The synergistic action of these two components makes Kayspas-Plus particularly effective in managing abdominal pain accompanied by spasmodic activity. It is indicated for the symptomatic treatment of abdominal cramps, dysmenorrhea, and other conditions involving smooth muscle spasms with inflammatory pain. Kayspas-Plus should be used under medical supervision, with caution advised in patients with a history of gastrointestinal ulcers, bleeding disorders, or hypersensitivity to NSAIDs or anticholinergic agents. Common side effects may include dry mouth, dizziness, nausea, and mild gastrointestinal disturbances.
How to use Kayspas-Plus Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kayspas-Plus Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Kayspas-Plus Tablet. Please consult your doctor.
High Risk
Information regarding the use of Kayspas-Plus Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Kayspas-Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Kayspas-Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Kayspas-Plus Tablet may be needed. Please consult your doctor.
Regular Checkup
Information regarding the use of Kayspas-Plus Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kayspas-Plus Tablet should be used with caution in patients with kidney disease. Dose adjustment of Kayspas-Plus Tablet may be needed. Please consult your doctor. Use of Kayspas-Plus Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Kayspas-Plus Tablet













